Office Of The Governor Statement On COVID-19 Monoclonal Antibody Treatment

65

Translate to Spanish or other 102 languages!

overnor Abbott’s doctor prescribed Regeneron's monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes
Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. Image for illustration purposes

Mega Doctor News

- Advertisement -

AUSTIN – Office of the Governor Communications Director Mark Miner today issued the following statement:

“Governor Abbott’s doctor prescribed Regeneron’s monoclonal antibody therapy treatment, which is available at no cost to all Texans who get a doctor’s referral. It is recommended that Texans testing positive for COVID-19 seek this antibody therapeutic drug because of its effectiveness to help keep people out of hospitals. Today, the Governor announced the continued expansion of COVID-19 Antibody Infusion Centers across Texas. That is in addition to more than 140 providers that are providing antibody treatment at hospitals and clinics across the state.”

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Local coalition encourages everyone to “Stomp Out Tobacco” with 5K run
Next article
More COVID-19 Antibody Infusion Centers Throughout Texas On The Way

More Articles

DHR Health Expands Cancer Care Services with Radiation Oncologist, Dr. Jason Shumadine Wolff

DHR Health, one of the largest physician-owned hospitals in the United States and a proud healthcare provider for the Rio Grande Valley since 1997, is delighted to welcome Dr. Jason Shumadine Wolff, to its growing network of specialty care physicians.

Dr. Michael Seawell Discusses Renal Denervation for Difficult-to-Control High Blood Pressure

Dr. Michael Seawell, a board-certified interventional cardiologist at DHR Health, is helping expand access to renal denervation, a minimally invasive treatment designed for patients with difficult-to-control high blood pressure.

DHR Health Continues to Lead the Way in Treatment of Alzheimer’s Disease for the RGV

Two years after DHR Health announced it was the first hospital south of San Antonio to successfully administer Leqembi, an FDA-approved intravenous treatment for early Alzheimer’s disease, DHR Health continues to expand access to advanced Alzheimer’s care for patients in the Rio Grande Valley being now the only facility doing amyloid PET Scans, a diagnostic test to accurately diagnose Alzheimer’s disease. DHR Health also offers Kisunla, another FDA-approved intravenous treatment for early symptomatic Alzheimer’s disease.

DHR Health Celebrates Graduating Class of Medical Residents, Fellows, and Pharmacy Residents

DHR Health proudly celebrated the accomplishments of its graduates from their Graduate Medical Education (GME) program during a special graduation ceremony held on June 13, 2026, at the Edinburg Conference Center at Renaissance.
- Advertisement -